** Shares of medical equipment maker West Pharmaceuticals WST.N rise 1.3% to $221 premarket

** Company raised its annual profit forecast to $6.15 to $6.35 a share, up from a previous range of $6 to $6.20 a share

** This profit raise comes despite the company anticipating a $20 million to $25 million hit from U.S. President Donald Trump's tariffs

** Analysts on average were expecting annual profit of $6.14/share, as per data compiled by LSEG

** WST posts Q1 revenue of $698 million, beating Wall Street estimate of $685.84 million

** Co reports Q1 adj. profit of $1.45/share, vs analysts' estimate of $1.23/share

** As of last close, WST stock down 33.4% YTD

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))